Current FDA-approved uses for semaglutide include : Type 2 diabetes management (glycemic control) Cardiovascular risk reduction in type 2 diabetes with established CVD (Ozempic) Cardiovascular risk reduction in adults with established CVD and obesity/overweight (Wegovy) Chronic weight management in obesity or overweight with comorbidities Clinicians should prescribe semaglutide according to FDA-approved indications and established clinical guidelines, including those from the American Diabetes Association (ADA) and American College of Physicians (ACP)
The goal should be improved metabolic function, better body composition, and a lower-risk physiologic state
doi: 10.1161/CIRCULATIONAHA.113.005081 34 CastanedaAMDutra-RufatoAJuarezMJGrosembacherLGonzalez-TorresHMussoCG
However, this litigation is much earlier in the process than those involving stomach paralysis
Addressing cost concerns, Jrgensen said his company offers a patient assistance program to American households earning less than $120,00 (89,619), "the only company having such a support program", he says
